Antibacterial Agents TRIZ Cases

Controlled alkaline lysis reduces toxicity and allergenicity while preserving antigenic determinants in bacterial extracts.

Peptide constructs combine targeting sequences with cell-penetrating carriers to block EspZ function, reducing Enteropathogenic Escherichia coli colonization.

Splitting microfibers creates barbs for exfoliation and reservoirs for ingredient storage, eliminating separate peeling devices.

A silicone fluid and fumed silica composition delivers pharmaceutical agents to wounds.

Monoclonal antibodies bind Acinetobacter baumannii to enhance macrophage uptake, addressing antibiotic resistance and improving survival rates.

EIPE-1 ligates quaternary ammonium arms onto a melanin-inspired indole core, destroying resistant pathogens while protecting eukaryotic cells.

Segmented DVD structures with standardized linkers reduce molecular heterogeneity and immunogenicity while maintaining dual antigen targeting.

Arf6 inhibitors selectively block vascular permeability to treat acute lung injury and macular degeneration without suppressing immune responses.

PEG spacers resolve aggregation in lipophilic adjuvants by mediating solubility while preserving TLR-2 immune activation.

Macrocyclic peptides bind PD-L1 to block receptor interactions, restoring T cell activation against cancer.

Intra-granular microcrystalline cellulose enables rapid bedaquiline fumarate dispersion.

Nanoparticle-conjugated antibiotics concentrate at infection sites, reducing nephrotoxicity and overcoming antibiotic resistance in resistant pathogens.

Intranasal ΔE1E3 adenovirus particles bypass needle pain and fear while inducing rapid, prolonged immunity without systemic inflammation.

Stem cells cultured with NOD2 agonists secrete PGE2 and TGF-β1 to suppress immune responses without side effects.

A liquid topical pharmaceutical composition seals wounds and absorbs exudation, preventing dressing adhesion and tissue tearing during replacement.

Segmented Janus nanoparticles combine charged and hydrophobic hemispheres to disrupt bacterial membranes.

Oligomeric tannins prevent antibiotic resistance by blocking bacterial adhesion to urothelial cells via intravesical delivery.

Surface-conjugated nanoparticles shield siRNA from enzymatic degradation while enabling transdermal penetration to suppress gene expression in lesional skin.

A monoclonal antibody binds the Stx2 epitope to neutralize cytotoxicity and prevent systemic damage.

Permanent positive charges confine blockers inside nociceptors, preventing unwanted effects on non-pain-sensing neurons and reducing neurogenic inflammation.

Evaporative crystallization produces stable granaticin B Form A, resolving low yield and degradation issues in large-scale production.

Removing poly-G tracts from parA promoters eliminates phase variation while maintaining high antigen levels in outer membrane vesicles.

Treponema bacterin vaccines with supplemental antigens overcome poly-microbial infection recurrence by establishing targeted prophylactic immunity.

Pleuromutilin derivatives modify chemical structures to enhance antimicrobial activity against diverse microbial pathogens.

N-methyl-amidoxime modifications transform PBP2 inhibitors into potent PBP3 agents that reduce bacterial load in resistant strains.

Barley malt extract enzymes break down complex feed carbohydrates to enhance energy utilization in avian granivores.

Sequence-dependent RNA motifs activate TLR8 to induce pro-inflammatory cytokines while minimizing interferon-alpha production.

NP16 compounds inhibit staphyloxanthin biosynthesis, reducing bacterial virulence and restoring immune susceptibility against resistant infections.

Optimized bicyclic heteroaromatic cores cross the blood-brain barrier to treat neurodegenerative diseases.

Oral Enterococcus agents prevent pneumococcal infections without antimicrobial resistance, addressing inadequate vaccine compliance and treatment efficacy.

Liposome formulations deliver lipid-based adjuvants that activate Toll-like receptor 2 to stimulate robust antibody production.

Macrocyclic peptides bind PD-L1 to block immune checkpoints, restoring T-cell activity against cancer and infections.

Selective benzimidazole agents inhibit spore germination to reduce relapse rates and environmental contamination.

Formaldehyde treatment induces intra-molecular cross-linking in recombinant botulinum peptides, resolving aggregation issues and boosting immunogenicity.

A flagellin aerosol composition uses acetate or phosphate buffers with polysorbate surfactants to maintain protein stability during nebulization.

N-acylated nitrogen heterocycles modulate the EthA pathway to enhance ethionamide activity, reducing required dosage and side effects in tuberculosis treatment.

Administering alginate oligomers reduces slow intestinal transit times, preventing bacterial overgrowth in cystic fibrosis patients.

Converting harmful deoxynivalenol into a conjugated antigen enables simultaneous protection against viral, bacterial, and mycotoxin disorders in swine.

Single-step synthesis of amphiphilic prodrug gelators enables enzyme-mediated drug release while eliminating toxicity from persistent polymer degradation.

Phenothiazine-pyridine compounds absorb near-infrared light to generate cytotoxic radicals and singlet oxygen.

Mitoflavoscins target flavin enzymes to inhibit mitochondrial respiration, eliminating cancer stem cells while sparing normal tissue from acute toxicity.

Pyrimidine derivatives activate toll-like receptor 7 to treat viral and allergic diseases while improving activation specificity.

Antibody fragment conjugates attach cytotoxic payloads to lysine residues, overcoming aggregation limits in solid tumor delivery.